Flex Pharma, Inc. (NASDAQ:FLKS) announced that the recently completed study in nocturnal leg cramps (NLC) has been selected for late-breaking oral and poster presentations at the American Academy of Neurology (AAN) 68th Annual Meeting being held in Vancouver, B.C., Canada. Only 14 abstracts are selected as late-breaking presentations at the AAN annual meeting. Flex Pharma is a biotechnology company developing innovative and proprietary treatments for NLC, cramps and spasms associated with severe neuromuscular conditions, and exercise-associated muscle cramps. Details from the study, titled “Orally-administered TRPV1 and TRPA1 activators reduce Night Leg Cramps in a randomized, blinded, placebo-controlled, crossover human trial,” will be presented on Tuesday, April 19, 2016, during the Emerging Science Session at 6:21 p.m. PDT, followed by a poster presentation from 6:30-7:15pm PDT.
On Tuesday Flex Pharma, Inc. (NASDAQ:FLKS) share price closed at $11.10. Its return on equity (ROE) is -28.80%. Flex Pharma, Inc. (NASDAQ:FLKS) is -60.22% away from its 52 week high and its 52 week range is $6.48 – 24.82.
Industrial Services of America, Inc. (NASDAQ:IDSA) announced the filing of its Form 10-K for the Fiscal Year Ended December 31, 2015. Net Loss improved from a loss of $7.3 million in 2014 to a loss of $1.8 million in 2015. This improvement was largely a result of a one-time gain of $6.0 million on the sale of substantially all assets of the Company’s Waste Services Segment. In total, the Company paid down, net of draws, $16.3 million of debt during 2015. Subsequent to December 31, 2015, the Company refinanced its working capital line of credit with a new $6.0 million asset-based revolving facility.
Industrial Services of America, Inc. (NASDAQ:IDSA) traded 12945 shares and its share price fell -6.41% to close at $2.63. Company has 45.91% insider ownership. Industrial Services of America, Inc. (NASDAQ:IDSA) quarterly performance is 56.55% while its year to date (YTD) performance is 100.76%.
Five9, Inc. (NASDAQ:FIVN) had its price objective upped by Canaccord Genuity from $10.00 to $11.00 in a report published. They currently have a buy rating on the stock. A number of large investors recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD raised its stake in Five9 by 5.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,823,600 shares of the company’s stock worth $41,965,000 after buying an additional 257,910 shares in the last quarter.
On Tuesday shares of Five9, Inc. (NASDAQ:FIVN) ended up at $9.55. This year Company’s Earnings per Share (EPS) growth is 48.00% and next year’s EPS growth is 65.20%. Beta of Five9, Inc. (NASDAQ:FIVN) is 2.88 while company weekly performance is 14.51%.
Quad/Graphics, Inc. (NYSE:QUAD) released Millennials: An Emerging Consumer Powerhouse, a report spotlighting best methods for marketers, advertisers and media partners to capture the attention of the connected Millennial market, defined as those born between 1981 and 1997. The report includes: Explores Millennials’ media engagement preferences and attitudinal behaviors across five key industry verticals: Grocery, Retail, Restaurant, Automobile and Financial Services. Examines the impact various media channels have on their behavior and, ultimately, their purchasing decisions. These channels include, but are not limited to, catalogs, mobile, direct mail, email, social media, retail inserts and magazines.
Quad/Graphics, Inc. (NYSE:QUAD) increased 2.76% to close at $12.65 on 29 March. Its return on assets (ROA) is -18.70% while return on investment (ROI) is -30.70%. Quad/Graphics, Inc. (NYSE:QUAD) price to sales (P/S) ratio is 0.14.
Gerdau S.A. (NYSE:GGB) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors. Separately, Bank of America lowered shares of Gerdau SA from a “neutral” rating to an “underperform” rating in a report. A number of institutional investors have recently added to or reduced their stakes in the stock. Two Sigma Investments LLC purchased a new position in Gerdau SA during the fourth quarter valued at about $1,241,000. Millennium Management LLC raised its position in Gerdau SA by 85.9% in the fourth quarter.
On 29 March Gerdau S.A. (NYSE:GGB) ended the day at $1.66. Company net profit margin stands at -10.60% whereas its return on equity (ROE) is -13.30%. Gerdau S.A. (NYSE:GGB) is -54.05% away from its 52 week high.